Collaborate with a Multidisciplinary Heart Valve Team to get your patients the intervention they need

The 2020 ACC/AHA Guideline for the Management of Valvular Heart Disease recommends that all patients with symptomatic severe heart disease be evaluated by a Multidisciplinary Heart Valve Team when intervention is considered.1 Collaborative, multidisciplinary heart teams are also strongly recommended by the 2019 Canadian Cardiac Society (CCS) Position Statement and the 2021 ESC/EACTS Guidelines. Heart Valve Centers can help optimize patient outcomes through improved decision-making and matching of patients to providers with appropriate expertise, experience, and resouces.1

The Heart Team depends on your valuable input and your patient benefits as you and the Heart Team collaborate to provide a personalized treatment pathway, from evaluation, imaging, therapy, to follow up. As underscored by the ACC/AHA, CCS, and ESC/EACTS, the Multidisciplinary Heart Valve Team helps present the patient with all appropriate treatment options in a balanced manner, using tools and techniques for shared decision-making in which patient preferences are considered.1 You can feel confident with the informed, guideline-based, multidisciplinary assessment your patient will receive.

Taking a collaborative approach, the Heart Team builds on the foundation of the care you provide your symptomatic severe AS patient.

References:   1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020. Epublished DOI: 10.1016/j. jacc.2020.11.018.